Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23208878 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults
Condition: Dengue
Intervention: Biological: Live attenuated tetravalent dengue vaccine

Indicates status has not been verified in more than two years